Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 1999
To determine if Thalidomide modulates the production of HIV-suppressor factors (MIP-1 alpha, MIP-1 beta, Rantes) and TH1 type cytokines (IL-12 and INF-gamma) in HIV-infected patients and alters viral load.
Epistemonikos ID: f17cbdc7297fd00b289c3611a8d6ca643f71f0d1
First added on: Dec 01, 2021